As of 11:29am ET
| -0.175 / -1.48%|
The 6 analysts offering 12-month price forecasts for Sucampo Pharmaceuticals Inc have a median target of 17.00, with a high estimate of 30.00 and a low estimate of 11.00. The median estimate represents a +45.61% increase from the last price of 11.68.
The current consensus among 6 polled investment analysts is to Buy stock in Sucampo Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.